Education
About Us
Working with TipRanks
Follow Us
LianBio Sponsored ADR (LIANY)
OTHER OTC:LIANY
LIANY Stock Chart & Stats
$0.08
<$0.01(1.14%)
At close: 4:00 PM EST
$0.08
<$0.01(1.14%)
Day’s Range― - ―
52-Week Range$0.03 - $0.44
Previous CloseN/A
Volume3.21K
Average Volume (3M)120.02K
Market Cap
$9.28M
Enterprise ValueN/A
Total Cash (Recent Filing)$567.37M
Total Debt (Recent Filing)$2.46M
Price to Earnings (P/E)―
Beta0.99
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Jul 15, 2025Dividend YieldN/A
Share Statistics
EPS (TTM)2.91
Shares Outstanding108,062,640
10 Day Avg. Volume90,792
30 Day Avg. Volume120,018
Financial Highlights & Ratios
PEG Ratio-0.12
Price to Book (P/B)0.46
Price to Sales (P/S)0.00
P/FCF Ratio7.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
LianBio Sponsored ADR News
LIANY FAQ
What was LianBio Sponsored ADR’s price range in the past 12 months?
LianBio Sponsored ADR lowest stock price was $0.03 and its highest was $0.44 in the past 12 months.
What is LianBio Sponsored ADR’s market cap?
LianBio Sponsored ADR’s market cap is $9.28M.
When is LianBio Sponsored ADR’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were LianBio Sponsored ADR’s earnings last quarter?
Currently, no data Available
Is LianBio Sponsored ADR overvalued?
According to Wall Street analysts LianBio Sponsored ADR’s price is currently Overvalued.
Does LianBio Sponsored ADR pay dividends?
LianBio Sponsored ADR pays a Notavailable dividend of $0.43 which represents an annual dividend yield of N/A. See more information on LianBio Sponsored ADR dividends here
What is LianBio Sponsored ADR’s EPS estimate?
LianBio Sponsored ADR’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LianBio Sponsored ADR have?
LianBio Sponsored ADR has 108,062,640 shares outstanding.
What happened to LianBio Sponsored ADR’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of LianBio Sponsored ADR?
Currently, no hedge funds are holding shares in LIANY
Company Description
LianBio Sponsored ADR
LianBio Sponsored ADR (LIANY) is a biopharmaceutical company focused on bringing innovative medicines to patients across China and other Asian markets. The company operates in the healthcare sector, specializing in the development and commercialization of therapeutics addressing unmet medical needs in oncology, cardiovascular, and other critical disease areas. LianBio collaborates with leading global life science companies to license and develop potential breakthrough therapies for its target regions.
Technical Analysis
VivoSim Labs
―
Qualigen Therapeutics
―
PharmaCyte Biotech
―
SciSparc Ltd.
―
Polyrizon Ltd.
―
Ownership Overview
―
Insiders
0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---